Cost-Effectiveness of One Session Treatment (OST) for Children and Young People with Specific Phobias Compared to Multi-Session Cognitive Behavioural Therapy (CBT): Results from a Randomised Controlled Trial
Author(s)
Wang HI1, Wright B2, Tindall L2, Cooper C3, Biggs K3, Lee E3, Teare MD4, Gega L2, Scott AJ5, Hayward E2, Solaiman K3, Davis T6, McMillan D2, Gilbody S2, Parrott S2
1University of York, York, YOR, UK, 2University of York, York, UK, 3University of Sheffield, Sheffield, UK, 4Newcastle University, Newcastle, UK, 5Keele University, Newcastle, UK, 6University of Alabama, Tuscaloosa, AL, USA
OBJECTIVES: In the UK, around 93,000 children and young people (CYP) experience specific phobias with a substantial impact on daily life. The current gold-standard treatment (multi-session cognitive behavioural therapy - CBT) is effective at reducing specific phobia severity; however, it is time consuming, requires specialist therapists, and can be costly with limited availability. It has been found one-session treatment (OST), a briefer variant of CBT, offers similar effectiveness. The aim of this study was to assess the cost-effectiveness of OST compared to multi-session CBT for CYP with specific phobias through ASPECT, a two-arm, pragmatic, multi-centre, non-inferiority randomised controlled trial.
METHODS: CYP aged 7 to 16 years with specific phobias were recruited nationally via the Health and Social Care pathways, randomised to the intervention group and control groups, and analysed (n=267). Resource use based on NHS and personal social services perspective and quality adjusted life years (QALYs) measured by EQ-5D-Y were collected at baseline and at six-month follow-up. Incremental cost-effectiveness ratio (ICER) was calculated, and non-parametric bootstrapping was conducted to capture uncertainty around the ICER estimates. The results were presented on a cost-effectiveness acceptability curve (CEAC). A set of sensitivity analyses (including taking a societal perspective) were conducted to assess the robustness of the primary findings.
RESULTS: After adjustment and bootstrapping, on average CYP in the OST group incurred less costs (incremental cost was -£302.96 (95% CI -£598.86 to -£28.61)) and maintained similar improvement in QALYs (gained 0.002 (95% CI −0.004 to 0.008)). The CEAC shows the probability of OST being cost-effective was over 95% across all the WTP thresholds. Results of a set of sensitivity analyses were consistent with the primary outcomes.
CONCLUSIONS: Compared to CBT, OST produced a reduction in costs and maintained similar improvement in QALYs. Results from both primary and sensitivity analyses suggested that OST was highly likely to be cost saving.
Conference/Value in Health Info
Value in Health, Volume 25, Issue 12S (December 2022)
Code
EE449
Topic
Economic Evaluation, Patient-Centered Research, Study Approaches
Topic Subcategory
Clinical Trials, Patient-reported Outcomes & Quality of Life Outcomes, Trial-Based Economic Evaluation
Disease
SDC: Mental Health (including addiction), SDC: Pediatrics